Egrifta Dosage

In general, anyone treating HIV-associated lipodystrophy takes the same dosage of Egrifta: 2 mg. The drug is injected subcutaneously in the stomach area. Egrifta has not been studied in children, the elderly, or people with decreased kidney or liver function -- they may require different amounts. Take care to not inject the medication into a muscle.

An Introduction to Dosing With Egrifta

There is only one standard dosage for Egrifta™ (tesamorelin acetate), regardless of your age or weight. As is always the case, do not adjust your dose unless your healthcare provider specifically tells you to do so.
 

Egrifta Dosage for HIV-Associated Lipodystrophy

The standard recommended dose for treating lipodystrophy in people infected with human immunodeficiency virus (HIV) is 2 mg injected just under the skin (subcutaneously) once daily. Dosing recommendations for children, elderly, or people with kidney or liver disease have not been established.
 

General Information on Using Egrifta

Some considerations to keep in mind during treatment with Egrifta include the following:
 
  • The injections are usually given in the fatty layer on the abdomen (the "stomach" area). Do not inject Egrifta into the muscle.
  • Make sure your healthcare provider shows you exactly how to prepare and inject an Egrifta dose.
  • For this drug to work properly, it must be taken as prescribed.
  • If you are unsure about anything related to your dosage, please talk with your healthcare provider, nurse, or pharmacist.
     

Egrifta Medication Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.